Endosense and GE Healthcare have inked a deal to jointly develop an all-in-one catheter ablation system for the treatment of cardiac arrhythmias.
Endosense is merging tip-to-tissue data from its force-sensing catheter with GE’s CardioLab electrophysiology recording and Innova imaging platforms.
"Our agreement with GE Healthcare is a meaningful validation of the industry’s growing recognition of the value of contact force-sensing in the electrophysiology lab," said Endosense CEO Eric Le Royer. "We are looking forward to partner with such an innovative and trusted industry leader. This system will deliver the combined benefits of our technologies to electrophysiologists and their patients."
Endosense forged a similar deal with Siemens AG’s (NYSE:SI) healthcare unit earlier this year, tying its force-sensing catheter to Siemens’ 3D cardiac imaging products to create software that enables electrophysiologists to visualize catheter tip to tissue force within a three-dimensional heart model during ablation procedures.